Edition:
United States

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Global Market

0.48USD
23 Feb 2018
Change (% chg)

$0.01 (+2.11%)
Prev Close
$0.47
Open
$0.47
Day's High
$0.48
Day's Low
$0.47
Volume
42,548
Avg. Vol
38,918
52-wk High
$4.50
52-wk Low
$0.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.280
Jun '17 0.00 -0.197
Mar '17 0.00 -0.199
FY 2016 Dec '16 0.00 -0.170
Sep '16 0.00 -0.194
Jun '16 0.00 -0.162
Mar '16 0.00 -0.235
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 6.65
Earnings (per share)
Quarter Ending Mar-18 1 -0.17 -0.17 -0.17 -0.21
Quarter Ending Jun-18 1 -0.17 -0.17 -0.17 -0.21
Year Ending Dec-18 1 -0.61 -0.61 -0.61 -0.83
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.28 33.62
P/E High - Last 5 Yrs. 26.83 73.80 46.17
P/E Low - Last 5 Yrs. 26.83 20.88 24.19
Beta 2.66 0.86 0.81
Price to Sales (TTM) -- 11.51 8.35
Price to Book (MRQ) 1.15 4.42 5.22
Price to Tangible Book (MRQ) 1.15 6.21 6.44
Price to Cash Flow (TTM) -- 23.19 25.88
% Owned Institutions 11.53 27.40 2.30

Dividends

  Company industry sector
Dividend Yield -- 0.73 1.52
Dividend Yield - 5 Year Avg -- 0.68 2.01
Dividend 5 Year Growth Rate -- 5.73 5.23
Payout Ratio(TTM) -- 16.41 41.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 15.57 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 9.38 7.57
Sales - 5 Yr. Growth Rate -- 4.30 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago -44.24 38.52 16.24
EPS (TTM) vs TTM 1 Yr. Ago -10.63 -- --
EPS - 5 Yr. Growth Rate -- 5.84 11.55
Capital Spending - 5 Yr. Growth Rate -17.44 11.05 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.71 2.42
Current Ratio (MRQ) 5.04 2.21 3.39
LT Debt to Equity (MRQ) 3.62 33.05 12.39
Total Debt to Equity (MRQ) 6.74 44.66 15.84
Interest Coverage (TTM) -90.68 61.08 38.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.01 54.79
Gross Margin - 5 Yr. Avg. -- 55.95 52.59
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 14.90 14.70
Operating Margin (TTM) -- -10.93 4.10
Operating Margin - 5 Yr. Avg. -- 7.13 9.99
Pre-Tax Margin (TTM) -- -10.10 4.83
Pre-Tax Margin - 5 Yr. Avg. -- 6.43 10.24
Net Profit Margin (TTM) -- -12.74 1.55
Net Profit Margin - 5 Yr. Avg. -- 4.04 6.54
Effective Tax Rate (TTM) -- 19.78 21.93
Effective Tax Rate - 5 Yr. Avg. -- 20.65 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 14,553,706 817,554,851
Net Income/Employee (TTM) -743,649 1,146,893 95,586,843
Receivable Turnover (TTM) -- 5.15 5.44
Inventory Turnover (TTM) -- 4.39 3.52
Asset Turnover (TTM) 0.00 0.76 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -94.76 1.52 10.73
Return on Assets - 5 Yr. Avg. -118.83 5.63 12.03
Return on Investment (TTM) -112.30 9.69 13.63
Return on Investment - 5 Yr. Avg. -273.41 7.46 15.76
Return on Equity (TTM) -116.86 14.25 15.39
Return on Equity - 5 Yr. Avg. -337.83 10.45 17.03
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 40.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for InVivo Therapeutics Holdings Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.53%
# of Holders: 55
Total Shares Held: 3,951,496
3 Mo. Net Change: -437,155
# New Positions: 4
# Closed Positions: 8
# Increased Positions: 13
# Reduced Positions: 20
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.